
[Federal Register Volume 79, Number 48 (Wednesday, March 12, 2014)]
[Notices]
[Pages 14053-14054]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-05347]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket Nos. FDA-2013-M-0851, FDA-2013-M-0987, FDA-2013-M-0988, FDA-
2013-M-1017, FDA-2013-M-1095, FDA-2013-M-1159, and FDA-2013-M-1206]


Medical Devices; Availability of Safety and Effectiveness 
Summaries for Premarket Approval Applications

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is publishing a list of 
premarket approval applications (PMAs) that have been approved. This 
list is intended to inform the public of the availability of safety and 
effectiveness summaries of approved PMAs through the Internet and the 
Agency's Division of Dockets Management.

ADDRESSES: Submit written requests for copies of summaries of safety 
and effectiveness data to the Division of Dockets Management (HFA-305), 
Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, 
MD 20852. Please cite the appropriate docket number as listed in table 
1 when submitting a written request. See the SUPPLEMENTARY INFORMATION 
section for

[[Page 14054]]

electronic access to the summaries of safety and effectiveness.

FOR FURTHER INFORMATION CONTACT: Nicole Wolanski, Center for Devices 
and Radiological Health, Food and Drug Administration, 10903 New 
Hampshire Ave., Bldg. 66, Rm. 1650, Silver Spring, MD 20993-0002, 301-
796-6570.

SUPPLEMENTARY INFORMATION:

I. Background

    In accordance with sections 515(d)(4) and (e)(2) of the Federal 
Food, Drug, and Cosmetic Act (the FD&C Act) (21 U.S.C. 360e(d)(4) and 
(e)(2)), notification of an order approving, denying, or withdrawing 
approval of a PMA will continue to include a notice of opportunity to 
request review of the order under section 515(g) of the FD&C Act. The 
30-day period for requesting reconsideration of an FDA action under 
Sec.  10.33(b) (21 CFR 10.33(b)) for notices announcing approval of a 
PMA begins on the day the notice is placed on the Internet. Section 
10.33(b) provides that FDA may, for good cause, extend this 30-day 
period. Reconsideration of a denial or withdrawal of approval of a PMA 
may be sought only by the applicant; in these cases, the 30-day period 
will begin when the applicant is notified by FDA in writing of its 
decision.
    The regulations provide that FDA publish a quarterly list of 
available safety and effectiveness summaries of PMA approvals and 
denials that were announced during that quarter. The following is a 
list of approved PMAs for which summaries of safety and effectiveness 
were placed on the Internet from July 1, 2013, through September 30, 
2013. There were no denial actions during this period. The list 
provides the manufacturer's name, the product's generic name or the 
trade name, and the approval date.

 Table 1--List of Safety and Effectiveness Summaries for Approved PMAs Made Available From July 1, 2013, Through
                                               September 30, 2013
----------------------------------------------------------------------------------------------------------------
              PMA No., Docket No.                    Applicant        Trade name            Approval date
----------------------------------------------------------------------------------------------------------------
P120022, FDA-2013-M-0851.......................  QIAGEN            therascreen[supr  July 12, 2013.
                                                  Manchester Ltd.   eg] EGFR RGQ
                                                                    PCR Kit.
P110002, FDA-2013-M-0987.......................  LDR Spine USA,    Mobi-C[supreg]    August 7, 2013.
                                                  Inc.              Cervical Disc
                                                                    Prosthesis.
P120009, FDA-2013-M-0988.......................  PFM Medical AG..  Nit-              August 16, 2013.
                                                                    Occlud[supreg]
                                                                    PDA.
P120004, FDA-2013-M-1017.......................  Parascript, LLC.  Parascript[supre  August 22, 2013.
                                                                    g]
                                                                    AccuDetect[supr
                                                                    eg] 6.1.0.
P110009, FDA-2013-M-1095.......................  LDR Spine USA,    Mobi-C[supreg]    August 23, 2013.
                                                  Inc.              Cervical Disc
                                                                    Prosthesis.
P110040, FDA-2013-M-1159.......................  Medtronic         Medtronic         September 19, 2013.
                                                  Vascular.         Vascular
                                                                    Complete[supreg
                                                                    ] SE Vascular
                                                                    Stent System.
P120010, FDA-2013-M-1206.......................  Medtronic, Inc..  MiniMed 530G      September 26, 2013.
                                                                    System.
----------------------------------------------------------------------------------------------------------------

II. Electronic Access

    Persons with access to the Internet may obtain the documents at 
http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/default.htm.

    Dated: March 6, 2014.
Leslie Kux,
Assistant Commissioner for Policy.
[FR Doc. 2014-05347 Filed 3-11-14; 8:45 am]
BILLING CODE 4160-01-P


